Concord Healthcare Group Co., Ltd. (2453.HK) Stock

About Concord Healthcare Group Co., Ltd.

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company offers oncology-related services, including sale and installation of medical equipment and software; and management and technical support services to hospitals and radiotherapy centers. It also engages in leasing radiotherapy and diagnostic imaging equipment; trading of radiotherapy and diagnostic imaging equipment; technology promotion and application solutions; medical treatment and service, and equipment trading activities; and provision of cancer treatment services. Concord Healthcare Group Co., Ltd. was incorporated in 2008 and is headquartered in Beijing, China.

Concord Healthcare Group Co., Ltd. (2453.HK) stock trades at $0.84 with a market capitalization of $658.28M. The stock is valued at a price-to-earnings (P/E) ratio of -2.10, price-to-book of 0.31, price-to-sales of 1.43. Over the past 52 weeks the stock has ranged between $0.63 and $6.38, and currently trades 86.8% below its 52-week high.

On profitability, Concord Healthcare Group Co., Ltd. generates a return on equity (ROE) of -15.58%, an operating margin of -26.41%, a net profit margin of -55.79%.

Official website: www.concordmedical.com